Cargando…

Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country

OBJECTIVE: The primary percutaneous coronary intervention (PPCI) is the preferred reperfusion strategy for ST-segment elevation myocardial infarction (STEMI). The pharmacoinvasive strategy (PIs) is a reasonable alternative when prompt PPCI is not possible, especially in resource-limited regions. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chacón-Diaz, Manuel, Custodio-Sánchez, Piero, Rojas De la Cuba, Paol, Yábar-Galindo, Germán, Rodríguez-Olivares, René, Miranda-Noé, David, López-Rojas, Luis Marcos, Hernández-Vásquez, Akram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244071/ https://www.ncbi.nlm.nih.gov/pubmed/35768779 http://dx.doi.org/10.1186/s12872-022-02730-6

Ejemplares similares

Tratamiento del infarto agudo de miocardio en el Perú y su relación con eventos adversos intrahospitalarios: resultados del segundo registro peruano de infarto de miocardio con elevación del segmento ST (PERSTEMI-II)
por: Chacón-Diaz, Manuel, et al.
Publicado: (2021)

Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction
por: Helal, Ayman M., et al.
Publicado: (2018)

Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction
por: Sethi, Rishi, et al.
Publicado: (2023)

Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment
por: de Andrade Falcão, Felipe José, et al.
Publicado: (2013)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Sobrevida al año en pacientes con infarto de miocardio con elevación del segmento ST en el Perú
por: Chacón-Diaz, Manuel, et al.
Publicado: (2022)

Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
por: Zubaid, Mohammad, et al.
Publicado: (2020)

Pharmacoinvasive Strategy vs Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Study in Mexico City
por: Araiza-Garaygordobil, Diego, et al.
Publicado: (2020)

Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits
por: Arias-Mendoza, Alexandra, et al.
Publicado: (2023)

Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care centre in India
por: Alex, AG, et al.
Publicado: (2018)

Short- and long-term survival after ST-elevation myocardial infarction treated with pharmacoinvasive versus primary percutaneous coronary intervention strategy: a prospective cohort study
por: Kvakkestad, Kristin, et al.
Publicado: (2022)

Pharmacoinvasive strategy: An essential tool to avoid the reperfusion paradox in STEMI networks
por: Barriuso, Ignacio, et al.
Publicado: (2021)

Inferior ST-elevation myocardial infarction managed with a pharmacoinvasive strategy and conservative management of delayed atrioventricular block: classical case report
por: John, Thadathilankal-Jess, et al.
Publicado: (2020)

Response to “Pharmacoinvasive strategy: An essential tool to avoid the Reperfusion Paradox in STEMI networks”
por: Gopar-Nieto, Rodrigo, et al.
Publicado: (2021)

Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy
por: Moraes, Pedro Ivo M, et al.
Publicado: (2019)

STREAM at one year: Further evidence supporting a pharmacoinvasive strategy in patients with STEMI
por: ElGuindy, Ahmed M.
Publicado: (2015)

The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
por: Raja, Deep Chandh, et al.
Publicado: (2017)

Relationship Between Arterial Access and Outcomes in ST‐Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study
por: Shavadia, Jay, et al.
Publicado: (2016)

STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
por: ElGuindy, Ahmed M.
Publicado: (2014)

Study protocol of the PEruvian Registry of ST-segment Elevation Myocardial Infarction II (PERSTEMI-II) study
por: Chacón-Díaz, Manuel, et al.
Publicado: (2021)

Left ventricular global longitudinal strain following revascularization in acute ST elevation myocardial infarction – A comparison of primary angioplasty and Streptokinase-based pharmacoinvasive strategy
por: Paul, Amal, et al.
Publicado: (2017)

Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in Brazil
por: De Marqui Moraes, Pedro Ivo, et al.
Publicado: (2023)

Well-being in Latin America : drivers and policies /
por: Rojas, Mariano
Publicado: (2020)

Gender Differences in the Factors Associated with Alcohol Binge Drinking: A Population-Based Analysis in a Latin American Country
por: Hernández-Vásquez, Akram, et al.
Publicado: (2022)

Variables clínicas asociadas a no reflujo tras la intervención coronaria percutánea en el infarto de miocardio con elevación del segmento ST: análisis secundario del estudio PERSTEMI I y II
por: Paredes-Paucar, Cynthia, et al.
Publicado: (2022)

Procedure Time Comparison between Radial Versus Femoral Access in ST-Segment Elevation Acute Myocardial Infarction Patients Undergoing Emergent Percutaneous Coronary Intervention: A Meta-analysis of Controlled Randomized Trials
por: Mohandes, Mohsen, et al.
Publicado: (2018)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
por: Rojas-Cortés, Robin
Publicado: (2020)

Multiple sclerosis epidemiology in Latin America: An updated survey
por: Cristiano, Edgardo, et al.
Publicado: (2017)

The Advance of Fusarium Wilt Tropical Race 4 in Musaceae of Latin America and the Caribbean: Current Situation
por: Martínez, Gustavo, et al.
Publicado: (2023)

Hip fracture care—Latin America
por: Rojas, Luis Gerardo Padilla, et al.
Publicado: (2020)

COVID-19 Response in Latin America
por: Garcia, Patricia J., et al.
Publicado: (2020)

Treatment Effect of Percutaneous Coronary Intervention in Men Versus Women With ST‐Segment–Elevation Myocardial Infarction
por: Sulaiman, Samian, et al.
Publicado: (2021)

1st Latin American Congress on Automation and Robotics
por: Chang, Ignacio, et al.
Publicado: (2017)

1st Latin American School of Differential Equations
por: Figueiredo, Djairo, et al.
Publicado: (1982)

Fragility fracture systems, Latin America perspective
por: Rojas, Luis G. Padilla, et al.
Publicado: (2022)

Point prevalence survey of antibiotic use in hospitals in Latin American countries
por: Levy Hara, Gabriel, et al.
Publicado: (2021)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Cyclic ST-segment elevation after primary percutaneous coronary intervention
por: Jansen, W. P. J.
Publicado: (2020)

Effect of Ki-67 assessment in the distribution of breast cancer subtypes: Evaluation in a cohort of Latin American patients
por: Yábar, Alejandro, et al.
Publicado: (2017)

1st Latin American Workshop on Phenomenology of the Fundamental Interactions
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_r7s2l7ohqgghc5dbg9vq30urs9